Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0421 Advanced Prostate 8/21/2006 5/1/2010 99% Published
    Closed S0601 NON-HODGKINS: R-CHOP-V followed by VM maintenance therapy for MCL 8/15/2006 6/1/2008 100% Published
    Closed S0536 Phase II Carboplatin, Paclitaxel, Cetuximab and Bevacizumab in Adv. NSCLC 8/15/2006 9/15/2007 100% Published
    Closed S0528 Phase I Study of Lapatinib and Everolimus in Advanced Solid Tumors 9/1/2006 8/25/2009 100% Published
    Closed S0530 Phase II Relapsed or Refractory ALL 10/1/2006 8/1/2008 100% Published
    Closed S0500 ADVANCED: Therapeutic Strategy Using the CellSearch Assay for Metastatic Breast Cancer 10/1/2006 3/15/2012 100% Published
    Closed S0353 Local Bladder 11/15/2006 10/15/2009 100% Published
    Closed S0622 ADVANCED: Phase II Dasatinib Treatment for Bone-Metastasis Predominant MBC 3/15/2007 12/15/2010 100% Published
    Closed S0521 Phase III Maint. vs. Obs. for Low and Intermediate Risk APL 6/1/2007 19% Published
    Closed S0600 Colorectal Ph III irinotecan-based chemo + cetuximab or bevacizumab 6/15/2007 11/10/2010 11% Published
    Closed S0518 CARCINOID Ph III depot octreotide + either interferon alpha or bevacizumab 12/1/2007 9/1/2012 100% Published
    Closed S0727 Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 3/1/2008 9/1/2010 100% Published
    Closed S0777 Phase III LD vs. VLD for Induction, followed by Transplant in Multiple Myeloma 4/1/2008 2/1/2012 100% Published
    Closed S0502 GIST Ph III imatinib with or without bevacizumab 4/15/2008 10/1/2009 2% Published
    Closed S0000D Adenomatous Colorectal Polyps (ACP) 6/3/2008 5/28/2013 100% Published
    Closed S0720 Phase II Adjuvant NSCLC 11/15/2008 5/15/2012 100% Published
    Closed S0703 Phase II Older Previously Untreated Non-M3 AML 12/1/2008 93% Published
    Closed S0809 Cholangiocarcinoma Ph II capecitabine, gemcitabine, RT 12/1/2008 10/1/2012 100% Published
    Closed S0709 Phase II Carboplatin/Paclitaxel/Erlotinib vs Erlotinib Alone in Advanced NSCLC 12/1/2008 9/15/2014 54% Published
    Closed S0722 Phase II RAD001 in MPM 12/1/2008 9/15/2011 100% Published
    Scroll Table